Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a 12-week Supplementation With 400 mg Magnesium From Magnesium Citrate on Blood Sugar, Blood Pressure and Expression of Magnesium-sensitive Genes in Patients With Type II Diabetes

NCT03002545 is registered in ClinicalTrials.gov with Protina Pharmazeutische GmbH as lead sponsor.

NCT NCT03002545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03002545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a 12-week Supplementation With 400 mg Magnesium From Magnesium Citrate on Blood Sugar, Blood Pressure and Expression of Magnesium-sensitive Genes in Patients With Type II Diabetes
Lead sponsor
Protina Pharmazeutische GmbH
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
July 31, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of magnesium in diabetes